Radiotherapy News and Research RSS Feed - Radiotherapy News and Research

Radiation therapy (in North America), or radiotherapy (in the UK and Australia) also called radiation oncology, and sometimes abbreviated to XRT, is the medical use of ionizing radiation as part of cancer treatment to control malignant cells (not to be confused with radiology, the use of radiation in medical imaging and diagnosis).
Plymouth University selects Brain Tumour Research as official charity partner

Plymouth University selects Brain Tumour Research as official charity partner

Brain Tumour Research has been chosen by Plymouth University to be an official charity partner. Brain Tumour Research was launched in April 2009 to raise awareness of, and funding for, scientific research into brain tumours and improve outcomes for brain tumour patients. [More]
Sheffield Teaching Hospitals begins treating wet AMD patients with Oraya Therapy

Sheffield Teaching Hospitals begins treating wet AMD patients with Oraya Therapy

SHEFFIELD Teaching Hospitals NHS Foundation Trust has become the first NHS hospital in the UK to start offering its patients a new non-invasive treatment for wet age-related macular degeneration (wet AMD). [More]
Study reveals treatment trends for prostate cancer in Japan

Study reveals treatment trends for prostate cancer in Japan

There has been a recent increase in use of radiotherapy in Japanese men newly diagnosed with prostate cancer and a concomitant decrease in use of androgen deprivation therapy, study findings indicate. [More]
Research report on the global non-melanoma skin cancer market

Research report on the global non-melanoma skin cancer market

Reportlinker.com announces that a new market research report is available in its catalogue: Global Non-melanoma Skin Cancer Market 2014-2018 [More]
Feist-Weiller, Caris Life Sciences partner to offer breakthrough technology to cancer patients

Feist-Weiller, Caris Life Sciences partner to offer breakthrough technology to cancer patients

Doctors at the LSU Health Shreveport Feist-Weiller Cancer Center will now have access to innovative, precision-medicine technology that determines the unique biological characteristics of each individual patient's cancer tumor. [More]
Scientists find new clues to early detection, personalised treatment of ovarian cancer

Scientists find new clues to early detection, personalised treatment of ovarian cancer

Scientists at A*STAR's Institute of Medical Biology and the Bioinformatics Institute have found new clues to early detection and personalised treatment of ovarian cancer, currently one of the most difficult cancers to diagnose early due to the lack of symptoms that are unique to the illness. [More]
Access Pharmaceuticals enters into exclusive license agreement with Norgine

Access Pharmaceuticals enters into exclusive license agreement with Norgine

ACCESS PHARMACEUTICALS, INC., an emerging biopharmaceutical company, today announced that it had entered into an exclusive license agreement with Norgine B.V., a leading independent European specialty pharmaceutical company, for the commercialization of MuGard in Europe. [More]
Oraya awarded NIH grant to study how gold nanoparticles can enhance Wet AMD treatment

Oraya awarded NIH grant to study how gold nanoparticles can enhance Wet AMD treatment

Oraya Therapeutics, Inc. announced today that they have been awarded a $215,000 Small Business Technology Transfer Grant from the National Institutes of Health to investigate how Oraya Therapy, a low voltage stereotactic radiotherapy, and gold nanoparticles can further enhance the treatment of wet age-related macular degeneration (Wet AMD). [More]
MD Anderson partners with HIAE to address cancer burden in Brazil

MD Anderson partners with HIAE to address cancer burden in Brazil

The University of Texas MD Anderson Cancer Center has announced a partnership with Hospital Israelita Albert Einstein to pioneer multidisciplinary patient care in Brazil and advance MD Anderson's mission to eliminate cancer globally. [More]
Natural products from plants can protect skin against gamma radiation during radiotherapy

Natural products from plants can protect skin against gamma radiation during radiotherapy

Radiotherapy for cancer involves exposing the patient or their tumor more directly to ionizing radiation, such as gamma rays or X-rays. [More]
Cedars-Sinai investigators developing novel treatment for locally advanced pancreatic cancer

Cedars-Sinai investigators developing novel treatment for locally advanced pancreatic cancer

Investigators at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute are developing a novel, multistep investigational treatment for one of the most complex and difficult-to-treat forms of the disease, locally advanced pancreatic cancer. [More]
Understanding how some cells in the brain and nervous system turn cancerous

Understanding how some cells in the brain and nervous system turn cancerous

Scientists from the Sloan-Kettering Institute for Cancer Research in New York with the help of Plymouth University Peninsula Schools of Medicine and Dentistry have completed research which for the first time brings us nearer to understanding how some cells in the brain and nervous system become cancerous. [More]
Oraya Therapy now being offered at NHS hospital in the UK and at four prestigious university hospitals in Germany

Oraya Therapy now being offered at NHS hospital in the UK and at four prestigious university hospitals in Germany

Oraya Therapeutics, Inc. announced today that it is significantly expanding its presence in Europe, with Oraya Therapy being offered for the first time at a National Health Service hospital in the United Kingdom and at four prestigious university hospitals in Germany. Oraya Therapy is intended as a one-time, non-invasive treatment for wet Age-related Macular Degeneration, with the potential to maintain or enhance vision while significantly reducing the required number of anti-vascular endothelial growth factor (anti-VEGF) injections into the eye. [More]
New molecules and biopharmaceuticals enhance patient's immune response against tumors

New molecules and biopharmaceuticals enhance patient's immune response against tumors

Researchers at the University of Arkansas have been awarded $1.5 million from the National Cancer Institute at the National Institutes of Health to develop new molecules and biopharmaceuticals that enhance a patient's immune response against tumors. [More]

Xstrahl, MacroMedics sign contract to distribute state-of-the-art fixation devices in the USA

MacroMedics BV the innovation leader in patient fixation devices has signed a distribution contract with Xstrahl in the USA. Xstrahl have been successfully distributing MacroMedics in the UK for 3 years. This partnership has allowed radiotherapy centers across the UK to gain access to the innovative and versatile systems. Now Xstrahl will be offering these unique products to US hospitals. [More]
Varian receives 510(k) clearance from FDA for Calypso soft tissue Beacon transponder

Varian receives 510(k) clearance from FDA for Calypso soft tissue Beacon transponder

Varian Medical Systems today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a Calypso® soft tissue Beacon® transponder that can help enhance the precision of radiotherapy and radiosurgery treatments for cancer. [More]
Current guidelines are more detailed regarding DMP for people with breast cancer

Current guidelines are more detailed regarding DMP for people with breast cancer

The German Institute for Quality and Efficiency in Health Care (IQWiG) published the results of a literature search for evidence-based clinical practice guidelines on the treatment of people with breast cancer. [More]
Novocure: 18 physicians certified to prescribe NovoTTF Therapy in Europe and Israel

Novocure: 18 physicians certified to prescribe NovoTTF Therapy in Europe and Israel

Novocure, a commercial stage oncology company, announced today that 18 prominent neurosurgeons and neuro-oncologists at medical centers in Europe and Israel are trained and certified to prescribe NovoTTF Therapy. [More]
Yashoda Cancer Institute uses Varian Clinac medical linear accelerator for radiotherapy treatments

Yashoda Cancer Institute uses Varian Clinac medical linear accelerator for radiotherapy treatments

Clinicians at a leading cancer center in India have become the first in the country to commence advanced lung, liver and brain radiotherapy treatments using an upgraded Clinac medical linear accelerator from Varian Medical Systems. [More]
Medac Pharma's Rasuvo injection gets FDA approval for RA, pJIA and psoriasis

Medac Pharma's Rasuvo injection gets FDA approval for RA, pJIA and psoriasis

Medac Pharma, Inc., a privately held pharmaceutical company focused on the development of new molecules and improving the effectiveness of existing medicines, announced that the U.S. Food and Drug Administration has approved Rasuvo, a subcutaneous injectable methotrexate (MTX) therapy delivered in an auto-injector for rheumatoid arthritis (RA), polyarticular-course juvenile idiopathic arthritis (pJIA) and psoriasis. [More]